Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults - 21/11/24

Doi : 10.14283/jpad.2022.1 
Jason K. Longhurst 1, 2, 3, , J.L. Cummings 4, S.E. John 4, B. Poston 5, J.V. Rider 3, 6, A.M. Salazar 4, V.R. Mishra 7, A. Ritter 7, J.Z. Caldwell 7, J.B. Miller 7, J.W. Kinney 4, M.R. Landers 3
1 Department of Physical Therapy and Athletic Training, Saint Louis University, 63104, Saint Louis, Missouri, USA 
2 Department of Neurorehabilitation, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA 
3 Department of Physical Therapy, University of Nevada, Las Vegas, USA 
4 Department of Brain Health, University of Nevada, Las Vegas, USA 
5 Department of Kinesiology and Nutrition Sciences, University of Nevada, Las Vegas, USA 
6 Department of Occupational Therapy, Touro University, Henderson, Nevada, USA 
7 Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA 

a jason.longhurst@health.slu.edu jason.longhurst@health.slu.edu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Preclinical Alzheimer’s disease (AD) provides an opportunity for the study and implementation of interventions and strategies aimed at delaying, mitigating, and preventing AD. While this preclinical state is an ideal target, it is difficult to identify efficiently and cost-effectively. Recent findings have suggested that cognitive-motor dual task paradigms may provide additional inference.

Objectives

Investigate the relationship between dual task performance and amyloidosis, suggestive of preclinical Alzheimer’s disease and whether dual task performance provides additional information beyond a cognitive composite, to help in the identification of amyloidosis.

Design

Cross-sectional.

Setting

Outpatient specialty brain health clinical research institution in the United States.

Participants

52 cognitively healthy adults.

Measurements

The data included demographics, amyloid standardized uptake value ratio obtained via florbetapir-PET, neuropsychological testing, apolipoprotien E genotype, and dual task performance measures. Data were analyzed via hierarchal multiple linear regression or logistic regression, controlling for age, education, and apolipoprotien E genotype. Receiver operating characteristic curves were plotted, and sensitivity and specificity calculated via 2×2 contingency tables.

Results

There was a moderate relationship (rs>.30) between motor and cognitive dual task effects and amyloid standardized uptake value ratio (ps<.042). A strong relationship (r=.58) was found between combined dual task effect, a measure of automaticity derived from dual task performance, and amyloid standardized uptake value ratio (p<.001). Additionally, combined dual task effect showed promise in its unique contributions to amyloid standardized uptake value ratio, accounting for 7.8% of amyloid standardized uptake value ratio variance beyond cognitive composite scores (p=.018). Additionally, when incorporated into the cognitive composite, combined dual task effect resulted in improved diagnostic accuracy for determining elevated amyloid standardized uptake value ratio, and increased the sensitivity and specificity of the cognitive composite.

Conclussion

Dual task performance using the combined dual task effect, a measure of automaticity, was a moderate predictor of cerebral amyloidosis, which suggests that it has utility in the screening and diagnosis of individuals for preclinical AD. Additionally, when combined with the cognitive composite, the combined dual task effect improves diagnostic accuracy. Further research is warranted.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Dual-task interference, amyloid, preclinical Alzheimer’s disease, screening, motor impairments


Mappa


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 9 - N° 2

P. 297-305 - Aprile 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults
  • Catriona K. Lewis, O.M. Bernstein, J.D. Grill, D.L. Gillen, D.L. Sultzer
| Articolo seguente Articolo seguente
  • Disease Burden and Attributable Risk Factors of Alzheimer’s Disease and Dementia in China from 1990 to 2019
  • R. Li, J. Qi, Y. Yang, Y. Wu, P. Yin, M. Zhou, Z. Qian, M.H. LeBaige, S.E. McMillin, Haoyan Guo, Hualiang Lin

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.